Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians

AIDS Research and Human Retroviruses

Volumn 21, Issue 3, 2005, Pages 239-245

  Currier, Jeffrey R ^a   Harris, Matthew E ^a   Cox, Josephine H ^a   McCutchan, Francine E ^a   Birx, Deborah L ^a   Maayan, Shlomo ^b   Ferrari, Guido ^c  

^a US Military HIV Research Program   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; GENE PRODUCT; SYNTHETIC PEPTIDE;

ALLELE; ARTICLE; COHORT ANALYSIS; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR CLONING; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; HIV CORE PROTEIN P24; HIV-1; HLA-B ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES;

EID: 16444387579     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.239     Document Type: Article

References (22)

1. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
2. Borrow P, Lewicki H, Hahn BH, Shaw GH, and Oldstone MB: Virus-specific CDS+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110.
3. Klein MR, van Baalen CA, Holwerda AM, et al.: 1995. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;81:1365-1372.
4. Phillips RE, Rowland-Jones S, Nixon DF, et al.: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991;354:453-459.
5. Borrow P, Lewicki H, Wei X, et al.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-211.
6. Price DA, Goulder PJ, Klenerman P, et al.: Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997;94:1890-1895.
7. Goulder PJ, Phillips RE, Colbert RA, et al.: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-217.
8. Goulder PJ, Brander C, Tang Y, et al.: Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001;412:334-338.
9. Kelleher AD, Long C, Holmes EC, et al.: Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001;193:375-386.
10. Klein MR, Keet IP, D'Amaro J, et al.: Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994;169:1244-1249.
11. Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405-411.
12. Carrington M, Nelson GW, Martin MP, et al.: HLA and HIV-1: Hétérozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
13. Costello C, Tang J, Rivers C, et al.: HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women. AIDS 1999;13:1990-1991.
14. Migueles SA, Sabbaghian MS, Shupert WL, et al.: HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000;97:2709-2714.
15. Migueles SA, Laborico AC, Imamichi H, et al.: The differential ability of HLA B*5701 + long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J Virol 2003;77:6889-6898.
16. Gillespie GM, Kaul R, Dong T, et al.: Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 2002;16:961-972.
17. Ferrari G, Currier JR, Harris ME, et al.: HLA-A and -B allele expression and ability to develop anti-gag cross-clade responses in subtype C HIV-1-infected Ethiopians. Hum Immunol 2004;65:648-659.
18. Altfeld M, Addo MM, Rosenberg ES, et al.: 2003. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. 2003 AIDS;17:2581-2591.
19. Leslie AJ, Pfafferott KJ, Chetty P, et al.: HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004;10:282-289.
20. Madrigal JA, Belich MP, Hildebrand WH, et al.: Distinctive HLA-A,B antigens of black populations formed by interallelic conversion. J Immunol 1992;149:3411-3415.
21. Barber LD, Percival L, Arnett KL, et al.: Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J Immunol 1997;158:1660-1669.
22. Goulder PJ, Altfeld MA, Rosenberg ES, et al.: Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001;193:181-194.